Category: Include on Menu
-
VCI Global Clarifies US$125 Million Equity Purchase Facility With No Shares Issued
VCI Global (NASDAQ:VCIG) has confirmed that its US$125 million standby equity purchase facility provides optional access to capital over 36 months, rather than representing an immediate share issuance, while acknowledging the potential for future shareholder dilution. Key Investor Takeaways Why VCIG Stock Is in Focus VCI Global has issued a clarification regarding its recent Form…
-
NetClass Technology Expands Into AI Companion Smart Hardware With LinkeeBot Launch
NetClass Technology (NASDAQ:NTCL) has entered the AI companion smart hardware market through a new joint venture, introducing a consumer-focused product line as it seeks to diversify beyond its established education technology business. Key Investor Takeaways Why NTCL Stock Is in Focus NetClass Technology has officially launched its first interactive AI smart pet product, LinkeeBot, through…
-
Wall Street Futures Rise as Technology Stocks Look to Rebound Ahead of Inflation Data: Dow Jones, S&P, Nasdaq
US stock futures pointed to a higher opening on Friday, suggesting Wall Street could recover some of the losses recorded in the previous session as technology shares showed signs of stabilising and crude oil prices retreated. Nasdaq 100 futures advanced 0.7%, indicating renewed buying interest in technology stocks following Thursday’s sell-off, which was partly driven…
-
Delta Air Lines Shares Fall as Third-Quarter Earnings Miss Forecasts and Full-Year Outlook Is Cut
Delta Air Lines (NYSE:DAL) shares fell more than 2% in premarket trading on Friday after the US airline reported weaker-than-expected third-quarter earnings and reduced its full-year profit guidance, despite continued strength in passenger demand. The carrier posted adjusted earnings of $1.72 per share for the quarter, below analysts’ expectations of $1.92. Adjusted revenue reached $17.6…
-
Natera Receives FDA Breakthrough Device Designation for Multi-Cancer Early Detection Blood Test
Natera (NASDAQ:NTRA) has received Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its investigational multi-cancer early detection (MCED) blood test, marking a regulatory milestone in the company’s efforts to develop screening technology capable of identifying multiple types of cancer. The Austin, Texas-based diagnostics company said the designation followed an FDA assessment…
-
Quince Therapeutics Renames as IRulya Therapeutics, Advances Pulmonary Drug Development
Quince Therapeutics (NASDAQ:QNCX) has changed its name to IRulya Therapeutics Inc., effective October 9, 2026, as the biotechnology company shifts its focus towards developing an inhaled treatment for several serious lung diseases. The company announced that its shares will begin trading on the Nasdaq Capital Market under the new ticker symbol IRLA on October 12,…
-
Profound Medical and Telix Pharmaceuticals Partner to Advance Prostate Cancer Imaging and Treatment Education
Profound Medical (NASDAQ:PROF) and Telix Pharmaceuticals (NASDAQ:TLX) have signed a co-education agreement aimed at increasing physician awareness of how advanced diagnostic imaging can support treatment planning for prostate cancer. The collaboration will focus on the complementary use of Telix’s prostate-specific membrane antigen positron emission tomography (PSMA-PET) imaging products and Profound Medical’s MRI-guided TULSA-PRO treatment platform.…
-
Humana Says 95% of Medicare Advantage Members Are Enrolled in Plans Rated Four Stars or Higher for 2027
Humana (NYSE:HUM) reported that 95% of its Medicare Advantage members are enrolled in plans receiving quality ratings of at least four stars from the Centers for Medicare & Medicaid Services (CMS) for 2027, marking an improvement from the previous year. The US health insurer said 42% of its Medicare Advantage membership is covered by plans…
-
Evercore Sees Resilience in US Casual Dining Despite Slowdown Among Higher-Income Consumers
The US casual dining industry has demonstrated greater resilience in 2026 than investors may recognise, according to Evercore ISI, although recent trends suggest spending has begun to moderate among higher-income consumers. In a research note published on Friday, the investment firm said restaurant performance had remained relatively stable throughout the year, despite economic uncertainty and…
-
Citi Sees Strategic Potential in Starbucks-Chipotle Takeover Despite Investor Doubts
Citi analysts believe a potential acquisition of Chipotle Mexican Grill (NYSE:CMG) by Starbucks (NASDAQ:SBUX) could offer strategic advantages, although investors remain sceptical that a transaction will materialise. The assessment followed a Financial Times report on Wednesday indicating that Starbucks had worked with advisers in recent months on a possible takeover proposal for the Mexican-inspired restaurant…